Hutchison China MediTech Ltd ADR Stock
Hutchison China MediTech Ltd ADR gained 0.810% compared to yesterday.
Our community is currently high on Hutchison China MediTech Ltd ADR with 3 Buy predictions and 1 Sell predictions.
With a target price of 17 € there is a positive potential of 36.0% for Hutchison China MediTech Ltd ADR compared to the current price of 12.5 €.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 0.810% | 9.649% | 10.619% | -14.966% | 14.679% | -19.355% | -56.597% |
| China Traditional Chinese Medicine Co Ltd | 0.890% | 0.893% | -0.877% | -10.317% | 3.670% | -50.439% | -41.753% |
| China Resources Pharmaceutical Group Ltd | - | 1.646% | 0.407% | -22.813% | 3.782% | -27.883% | 21.675% |
| Repligen Corp. | -0.280% | -0.069% | 4.828% | -2.695% | 2.520% | -11.854% | -14.607% |
Comments
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $13.75 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat